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Application of atomic force microscopy
in cancer research
Xiangying Deng1,2,3, Fang Xiong2, Xiayu Li2,3, Bo Xiang1,2,3, Zheng Li1,2,3, Xu Wu2,4, Can Guo2, Xiaoling Li1,2,3,
Yong Li2,5, Guiyuan Li1,2,3, Wei Xiong1,2,3* and Zhaoyang Zeng1,2,3*

Abstract
Atomic force microscopy (AFM) allows for nanometer-scale investigation of cells and molecules. Recent advances
have enabled its application in cancer research and diagnosis. The physicochemical properties of live cells undergo
changes when their physiological conditions are altered. These physicochemical properties can therefore reflect
complex physiological processes occurring in cells. When cells are in the process of carcinogenesis and stimulated by
external stimuli, their morphology, elasticity, and adhesion properties may change. AFM can perform surface imaging and ultrastructural observation of live cells with atomic resolution under near-physiological conditions, collecting
force spectroscopy information which allows for the study of the mechanical properties of cells. For this reason, AFM
has potential to be used as a tool for high resolution research into the ultrastructure and mechanical properties of
tumor cells. This review describes the working principle, working mode, and technical points of atomic force microscopy, and reviews the applications and prospects of atomic force microscopy in cancer research.
Keywords: Atomic force microscopy, Cancer cells, Morphology, Mechanical properties
Background
As unconstrained and rapidly dividing cells, the physicochemical properties of cancer cells have changed in
comparison with the normal cells from which they are
derived [1]. During the invasion and metastasis of cancer cells, the adhesion between cells is reduced, and the
shape and hardness of the cells changes according to the
surrounding environment [2–4], in order to meet the
physiological activities of cancer cells themselves. Therefore, researchers can determine whether or not cells
are cancerous, whether the cancer cells are invasive or
metastasize, and the effects of drugs on cancer cells and
so on by the physical properties such as hardness, adhesion, and Young’s modulus. However, in order to achieve
the above research, it is necessary to observe and manipulate cells at a nanometer level of resolution. Atomic
force microscopy (AFM) is an extremely high resolution
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tool, which can be used to observe the morphology of
a sample, and quantitatively measure its mechanical
properties at atomic resolution. For this reason, AFM
has applications in cancer research. The technique was
invented in 1986 by IBM’s G. Binnig, and C. F. Quate and
C. Gerber at Stanford University [5]. AFM is the highestresolution and most widely used member of the scanning
force microscopy (SFM) family, with a horizontal resolution of 0.1 nm, a vertical resolution of 0.01 nm, and an
atomic level of resolution. It goes beyond the limits of the
resolution of microscopes which use light and electron
wavelengths. AFM uses a microscopic physical probe to
“grope” the microcosm and observes the morphology
of the sample under investigation in three-dimensional
space, obtaining information from the very weak interaction between the probe and the sample surface.
The technical advantages of AFM are the main reasons for its rapid and widespread adoption in biology
and medicine [6]. Firstly, due to the extremely high
resolution of AFM, it is possible to perform direct
three-dimensional imaging of molecular, and even
atomic-scale structures. Secondly, sample preparation
for AFM is straightforward, the damage to the original
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structure is small, and the original appearance of the
sample can be determined objectively and accurately.
Thirdly, due to the fact that samples can be observed
under near-physiological conditions, the dynamic processes of molecules, organelles, and other structures in
living cells can be recorded in real time by AFM [7].
Fourthly, AFM can measure intermolecular forces,
charge, pH, and other physicochemical characteristics
of sample materials. Finally, the functionalized probe
can be used to identify specific molecules or interaction forces such as ligand-receptor interactions.
Therefore, AFM has good prospects for application in
biomedicine and clinical medicine, and particularly in
the diagnosis and treatment of cancer. Cell mechanics
is a promising biomarker for indicating cell states [8–
13]. The mechanics of cells can be measured by many
methods including, among others, magnetic twisting
cytometry, optical tweezers, and atomic force microscopy. Of these methods, however, AFM is the most
widely used tool for this purpose [14–16]. The advantages and disadvantages of these methods are summarized in Table 1.
At present, the study of the physical properties of
tumors is not sufficiently thorough. In view of the
various unique advantages of AFM, it may be used to
investigate changes in ultrastructure and mechanical properties within tumor tissues and cells which, in
turn, can be used as a basis for clinical adjuvant diagnosis [17]. At the same time, AFM allows for the exploration of the mechanisms of antitumor drugs at the
cellular and molecular level; this allows for the evaluation of drug efficacy, and opens avenues for the prevention of tumor cell proliferation [18–22].
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The basic principle of AFM
The AFM system consists of the following components: a micro-cantilever with probe, a micro-cantilever
motion detection device, a feedback loop for monitoring
micro-cantilever motion, a piezoelectric ceramic scanning device for sample scanning, and a computer-controlled image acquisition, display, and processing system
(Fig. 1). AFM studies the surface structure and properties of the sample by detecting very weak interatomic
interactions between the sample surface and the probe
tip. The working principle is to fix one end of micro cantilever, which is extremely sensitive to weak force, while
other end of cantilever contained in the probe brought
into close proximity with the sample [23]. Once this
has been accomplished, a very weak force, which may
be either repulsive or attractive, exists between the tip
atom of the probe and the atoms of the sample surface.
The magnitude of this force changes the deformation of
the micro cantilever or its motion state. When the sample is scanned, sensors are used to detect these changes
and force distribution information is obtained, allowing
the user to obtain surface structure information with
nanometer resolution. The AFM scanner can move in the
X, Y, and Z directions. While the distance traveled in the
X and Y directions varies with the scanner, the vertical
Z direction is typically limited to a few microns. At the
same time, the morphology of the scanning area sample
can be obtained by reconstructing the position of the
piezoelectric ceramic scanning tube in the Z-direction
and the X–Y plane. The Young’s modulus value of samples, like cells and tissues, is fitted with a linear fit by
Hertz model, with a smaller Young’s modulus indicating that the sample is more susceptible to deformation.
The force-distance curve measured by AFM reflects the

Table 1 Comparison of representative methods in measuring cell mechanics [8, 14–16]
Methods

Advantages

Disadvantages

Microfluidics

High throughput (~ 1 cell/s); ability to control cell environ- Be prone to cell adhesion and clogging; limited materials
ment and approximate physiological conditions
for fabricating devices; cell size is often neglected

Micropipette aspiration

Simple and cost-effective; large range of force (up
to ~ 100 nN)

Low throughput; limited special resolution (< 1 cell/10 min);
possible damage to cells; mainly for suspended cells

Micropost arrays

Ability to measure the traction forces of single cells or cell
populations

Mainly for adherent cells; high cost and complexity; the
topology of micropost arrays may influence cell activities

Magnetic twisting cytometry Probing the local mechanics of cells; magnetic beads can
be bound with diverse types of cellular molecules or
structures

Low throughput (< 1 cell/min); difficult to standardize; only
for unidirectional forces

Optical tweezers

High precision measurements of small forces (0.01–103
pN); can be integrated with microfluidic delivery

Limited force (< 500 pN) applied on cells; detrimental effects
on cells due to heating

Parallel plate

Simple and cost-effective; ability to study single cells of
cell populations

Low throughout; low spatial resolution

Atomic force microscopy

Applicable for both suspended cells and adherent cells;
simultaneously obtain structural and mechanical information with nanometer resolution

Low throughput (< 1 cell/10 min); the mechanical poking of
the AFM tip may influence cell activities
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Fig. 1 Schematic diagram of AFM working principles. The AFM instrument is composed of a piezoelectric ceramic tube, a laser generator, a
position-sensitive photodiode detector, a controller, and an AFM probe. The AFM probe is a micro-cantilever with a sharp tip attached at its end.
The tip, which has a monomolecular point, allows for nanometer resolution imaging and the micro-cantilever is a force sensor that can detect even
minute deformation of a sample, enabling very high sensitivity AFM in force measurements

quantitative force between the tip and the sample. Using
the corresponding probes, equipped with dedicated software, AFM can measure the nano-indentation of the
micro regions, and force–displacement curves drawn on
this basis [24] can be used for the quantitative measurement of a material’s elastic modulus, adhesion, and stiffness (Fig. 2) [25]. Each force curve is saved during the test
for later quantitative analysis.
The principle of AFM imaging and mechanical property detection is based on the attraction and repulsive
forces between atoms. The atoms at the tip of the probe
and those on the surface of the sample are subjected to
an attractive force when too far apart, and to a repulsive
force when they are in close proximity (Fig. 3a). The basic
imaging modes of AFM include: contact mode (Fig. 3b),
non-contact mode (Fig. 3c), and tapping or semi-contact
mode (Fig. 3d). In contact mode, the probe of AFM keeps
a slight contact with the sample surface and maintains a
constant force. In non-contact mode, the surface topography of the sample is produced by measuring the atomic
attraction between the probe and the sample. In the tapping mode, the micro-cantilever of the probe is forced
to move near the resonance frequency, and the probe
makes contact with the sample intermittently. The force
between the probes and sample can be kept constant
by controlling the amplitude or deflection of the microcantilever when the probe touches the sample. Tapping
mode effectively eliminates the influence of the lateral
force and reduces the force caused by the adsorption

layer, resulting in a high image resolution, especially for
surface ultrastructure observation of biological samples.
The study of single cancer cells using AFM is expected
to be advantageous in two aspects. On the one hand, the
diagnosis of early cancer focuses on the observation of
changes and differences between single cells, with the
differences between cancerous and non-cancerous cells
allowing for early diagnosis and treatment of cancer [26].
On the other hand, it allows for the study of the structure
and function of cancer cells, the mechanisms involved in
their spreading, interaction processes between cells, and
the mechanisms of anti-cancer drugs, etc. The resultant
findings from such studies should aid researchers in their
goals of finding means of blocking cancer cell proliferation, and developing anti-cancer drugs [27–30].

Observation of cancer cells morphology
Using visible light microscopy, no significant differences
in the surface morphology of white blood cells could
be detected in cells from chronic leukemia patients and
healthy subjects. However, observations of both cells
under AFM revealed that a large number of needle-like
structures appeared on the surface of leukocytes in leukemia patients, and that cell surface roughness was also
significantly higher than that of normal white blood cells
[31]. This indicated that the resolution of the AFM is significantly higher than that of the optical microscope, and
is capable of distinguishing between differences in the
ultrastructure of the cells. In addition to observations of
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whether the cells are malignant or not, compared with
tumor cells from the same source. This provides a reliable
auxiliary basis for clinical pathological and differential
diagnoses.
In cancer cells, the expression of certain genes may be
either up-or down-regulated. For example, the CDX2
gene is less active in most patients with colorectal cancer
[33, 34]. Overexpression of CDX2 can inhibit the metastasis of this cancer, while further inhibiting its expression promotes metastasis [35, 36]. It has been shown
that CDX2 has tumor suppressing activity [37–39]. AFM
detection showed that the stiffness of colon cancer cells
increased with higher expression of CDX2, and that cell
variability decreased, which weakened the ability of the
cells to transfer to the extracellular matrix and capillaries [40]. Vascular endothelial growth factor D (VEGF-D)
and vascular endothelial growth factor C (VEGF-C) are
thought to be involved in the formation of lymphatic
vessels and blood vessels [41, 42]. After transfecting a
recombinant plasmid containing VEGF-D into lung cancer cells, AFM detection showed that irregular microspikes and nanoclusters appeared on the cell surfaces,
and that cells became more rigid. Using AFM to observe
the surface morphology of lung cancer cell PC9, the morphology image of cancer cells with high resolution could
be obtained (Fig. 4a–c). The above studies demonstrate
that AFM can be used to detect changes in the morphology of cancer cells caused by cancer-associated genes,
providing an additional detection method for phenotypic
changes which is complementary to traditional investigative methods.
Fig. 2 Force-distance curve-based AFM. a Principle of force-distance
(FD) curves by approaching (red) and withdrawing (blue) the AFM tip
from the sample. The tip of the cantilever is initially distant from the
sample [1] to which it is brought into contact [2]. During retraction [3]
of the AFM tip, adhesive events may occur at different distances due
to nonspecific [4] or specific [5] interactions between tip and sample.
b The force-curve plot from an AFM measurement. The slope value
is fitted with a linear fit (red line) (a), the adhesion is measured as a
single value and the mechanical value of the point (b) indicates the
adhesion force

tumor cell lines, AFM can also scan patient’s tumor tissue
or cells for imaging. Hanekar et al. explored the relationship between SMAR1 expression and cell surface roughness under AFM in different grades of human breast
cancer tissues [32]. This study illustrates that it is possible
to observe the ultrastructure of the membrane surface of
different types of tumor, and to analyze their common
characteristics and differences. AFM can also highlight
the significant differences in cell membrane morphology
between normal cells and tumor cells, and can determine

Mechanical properties of cancer cells
The mechanical strength of cells plays an important
role in the homeostasis of tissues, cell growth, division,
migration, and epithelial-mesenchymal transition [43].
Numerous studies have shown that differences exist in
the stiffness of normal and cancerous cells, and between
primary and metastatic cancer cells. Cross et al. detected
the cells of patients with suspected metastatic adenocarcinoma (lung, breast, and pancreatic cancer) using AFM.
Studies have indicated that, even if benign and malignant
cells are similar in shape and therefore difficult to distinguish by visual inspection, they may still be identified by
mechanical analysis [44, 45]. In addition, the Cross group
also reported biomechanical differences between human
mesothelial tumor cells and normal cells [46]. Other
researchers have found that human bladder cancer cells
have lower hardness than normal epithelial cells [47],
and that human breast cancer MCF-7 cells are softer
than MCF-10 cells [48]. These studies showed that it is
possible to distinguish between cancer cells and normal
cells, and between original and metastatic cancer cells,
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Fig. 3 Three basic working modes of AFM. a The curve of both interatomic force and intervals relation. b In contact mode the probe is always
slightly contact with the sample and scanned in a constant force mode. c In the non-contact mode the tip of the needle always vibrates on the
surface of the sample, but it is never contact with the sample. The scanning detector detects long-range forces such as van der Waals force or
electrostatic forces that do not damage the imaged sample. d In the tapping mode the micro cantilever is subjected to stress vibration near its
resonant frequency, and the oscillating needle tip gently strikes the surface of the sample, intermittently making contact with it

by detecting their mechanical properties using AFM.
This provides a novel auxiliary means of clinical cancer
diagnosis. The mechanical properties of lung cancer cell
PC-9, including Young’s modulus, adhesion, and stiffness, have also been quantitatively measured by AFM
(Fig. 4d–f ). This showed that AFM can not only detect
the morphology of cancer cells, but also perform deeper
mechanical properties and cell structure analysis on cancer cells.
The invasion and metastasis of tumor cells has an
important relationship with the microenvironment. AFM
measurement of extracellular matrix (ECM) micromechanics provides important insights into disease-induced
tissue stiffness alterations [49]. It was found that normal liver tissue, liver fibrosis tissue, and liver cirrhosis
were significantly different in terms of hardness when
examined by AFM. There was no significant difference
in hardness between liver cirrhosis tissue and hepatocellular carcinoma tissue [50]. This suggested that the
hardness of the liver is increased during carcinogenesis,

which may progress to liver cancer after cirrhosis. In
addition, a series of studies have shown that cancer cells
are more rigid than normal cells [51]. These findings disprove the idea that cancer cells tend to be softer than
normal cells, and indicate that hardness depends on the
needs of the cancer cells themselves during the process of
carcinogenesis.

The study of tumor‑associated molecules
and subcellular structures
Circulating cell-free DNA (ccfDNA) is an important biomarker for the diagnosis and treatment of cancer [52],
and can be indicative of changes in the genotype and
phenotype of primary tumors [53]. It has been found that
more than 80% of the ccfDNA fragments in the plasma
of cancer patients are under 145 bp in size, and that their
size is always less than 300 bp [54]. Reduced fragmentation of ccfDNA is associated with increased overall survival. After chemotherapy, plasma ccfDNA fragmentation
in normal patients is greatly reduced, while patients with
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Fig. 4 Imaging of cancer cell morphology and measuring the mechanical properties of cancer cells by AFM. a Representative AFM height image.
b Representative AFM deflection image. c 3D distribution of cell height. The force curve is used to calculate mechanical properties. d Image
representing Young’s modulus distribution. e Image representing adhesion force distribution. f Image representing stiffness distribution. Parameters
are displayed as colors. The results of morphology observation and mechanical properties measurement of the cell were from our study group

KRAS mutations have a greater degree of radiotherapy
resistance [55]. This demonstrated that AFM can be
used to detect the ccfDNA fragmentation index in cancer patients, and that this may be used as a potential biomarker for cancer treatment [56–59].
miRNAs play an important role in controlling various cellular processes, and their expression levels
can change with disease [60–65]. Northern blotting
is a standard method for miRNA quantification, but
requires a large amount of RNA for analysis and is
insensitive to low abundance RNA [66, 67]. qRT-PCR
is also used to quantitate miRNAs, but the length of
miRNAs and primers will, to some extent, hinder their
direct detection, which may also be affected by platform differences [68]. Neither of these techniques can
be used to perform in situ analysis of miRNAs, or to
provide information concerning their subcellular localization. Although nanopore sensors and the single-molecule fluorescence microscopes can be used for single
miRNA detection, their sensitivity is not strong [69–
72]. While enzyme-assisted fluorescence [73], nanoparticle [74], and in situ enrichment (Toehold-initiated

rolling circle amplification) [75] techniques can observe
single-molecule miRNA, their spatial resolution is
poor. AFM, however, is perfect for accurately quantifying miRNA content at the single cell level, allowing for
direct and high sensitivity in situ quantification [76].
AFM cannot only quantitate intracellular miRNAs, but
can also provide accurate information on their subcellular localization [77]. Therefore, cancer-associated
miRNA detection can be performed in situ using AFM,
which further extends the diagnostic methods available
for cancer [78, 79]. In addition, there are miRNAs in
the exosomes secreted by tumor cells which are considered to be related to the development of tumors. These
constitute a variety of tumor markers for breast cancer
[80–82], colon cancer [83, 84], lung cancer [85], thyroid
cancer [86], etc. AFM can be used for imaging analysis of exosomes with different separation modes, and
can analyze the effects of different separation methods
on the size of exosomes [87]. It can therefore be used
to detect cancer diagnosis markers including ccfDNA,
miRNA, and exosomes, strongly supplementing existing cancer detection and diagnosis methods.
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In addition, AFM can be used to observe the internal
structure of cancer cells. All signaling pathways for cancer cell metastasis go through the nuclear pore complex
(NPC), and small molecules can freely pass through
NPCs [88]. However, molecules larger than 40 kDa must
be combined with FG-Nups to pass through the nuclear
pore complex [88]. Using high-speed AFM (HS-AFM),
researchers were able to directly observe nano-scale
changes in the channels of the nuclear pores in dying
colon cancer cells (CRC), and found that these changes
were mainly in FG-Nups [89]. This suggested that HSAFM can measure high speed dynamic changes and disordered intracellular systems, and may be used as a cell
endoscope to study other organelles in cancer cells. These
results showed that AFM can not only measure the morphology and mechanical properties of cells, but can also
be used to locate and analyze corresponding molecular
and subcellular structures in cancer.

The study of the interaction between molecules
For cells, AFM can not only provide morphological information on their length, width, and height, but can also
be used to study fine structures such as receptors, lipid
rafts, and various pathways on membranes. AFM allows
researchers to study the activity of unique molecules on
individual cells under physiological conditions [90]. By
attaching specific molecules (such as ligands and antibodies) to AFM probes, they can locate and manipulate
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interacting proteins (such as receptors and antigens),
using a method called single-molecule force spectroscopy (SMFs) [91, 92] (Fig. 5). This is a powerful supplement to traditional methods to detect the interaction
between single molecules [93]. For example, Rituximab is
a monoclonal drug for the treatment of leukemia, which
is connected to the AFM probe surface [94] to measure
the distribution and binding of CD20 and FCR in tumor
and NK cells, respectively, and it was found that the binding force of CD20-rituximab is significantly greater than
that of FCR-rituximab, the frequency distribution of
CD20 in tumor cells was significantly higher than that
of FCR on NK cells. The above research suggested that
the study of interactions between molecules is feasible
by AFM, which can also be used to study the interactions
between cancer-related molecules.
Curcumin is a natural polyphenol complex, and a large
number of studies have shown that it has an inhibitory
effect on many cell lines [95–97], but has no toxic effect
on normal cells [98–100]. The CD44 antibody was connected to the AFM probe surface to measure CD44
distribution of the cell surface and the binding force
between CD44 and the antibody. Researchers found that
the binding force between the CD44 antibody and surface
CD44 in human hepatoma cells treated by curcumin was
decreased, and the expression of CD44 on cell surfaces
was also decreased in unit area [101]. This finding is similar to the results detected by the flow cytometry [101].

Fig. 5 Schematic diagram of AFM-based single-molecule force spectroscopy. a Individual antibodies or other molecules immobilized on a
functionalized tip are positioned above a cell adhering to a substrate. b Sample and tip molecules are then brought into contact for a defined
contact time and with a preset contact force. c The molecules are subsequently separated, and the maximal separation force and the detachment
work can be determined using a simultaneously recorded force–distance curve. d The cantilever is retracted until the tip and sample molecules
separate
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These studies help to explain the relationship between the
distribution of CD44 and the apoptosis of cancer cells, as
suggest the possibility of tumor therapy by blocking the
CD44 molecule on the tumor cell with CD44 antibody.
Results of this type show that AFM has good application
value in the study of tumor-related molecules.
AFM has many advantages in detecting the interaction
between molecules. Compared with traditional methods such as surface plasmon resonance [102], radioimmunoassay [103], and fluorescence resonance energy
transfer [104], SMFs can be used to directly measure
molecular interactions on the surface of living cells, but
in relatively shorter time and at lower cost. The information obtained from SMFs analysis in conjunction with
clinical data can help researchers discover biomarkers for
efficient tumor prediction and diagnosis.

Evaluation and development of antitumor drugs
It is of potential value to estimate the effect of anticancer drugs by regulating changes in the morphological
and mechanical properties of cancer cells [105–107].
It is generally believed that decreased adhesion of cancer cells is the first step in metastasis. Disulfiram (DSF)
is a commonly used clinical hangover drug [108]. However, studies have shown that the DSF-Cu complex has
an anti-tumor effect [109]. The stiffness and adhesion
of nasopharyngeal carcinoma cells treated with DSF-Cu
have been shown to be increased [110], which suggested
that DSF-Cu reduces the deformability and enhances the
adhesion of these cells. DSF-Cu may, therefore, inhibit
the malignant growth and metastasis of nasopharyngeal
carcinoma cells.
Changes in the deformability and adhesion of cancer cells may be due to major changes in the morphology and structure of the cell surface following drug
treatment. After treatment of colon cancer cells with
AEE788 and Celecoxib, their cell surfaces became
rough and severely contracted, with pseudopodia and
filopodia disappearing completely [111]. The morphology and ultrastructure of Hela and HepG2 cells were
also changed after being treated by colchicine and cytidine, and the degree of damage to cancer cells varied
with the concentration of the drugs, and the timing of
their administration [112]. These findings suggested
that the surface morphology of cells can change dramatically after stimulation by drugs or bioactive compounds. In addition, the efficacy of drugs can be judged
by their effects on cell surface roughness and hardness.
Prostate cancer is a malignant tumor that occurs in the
prostate gland of men. Ren et al. evaluated the effects
of eight anticancer drugs against this cancer using AFM
[113]. They found that the Young’s modulus of PC-3
cells increased significantly after treatment with eight
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drugs, and the mechanism of action of drugs on the
mechanical properties of PC-3 cells was different. These
studies suggested that AFM can be effectively used in
the screening and evaluation of anticancer drugs.
The development of new anti-cancer drugs is essential for the treatment of cancer. Most of the anti-tumor
drugs are cytotoxic substances. Due to their poor specificity, they can also cause damage to human normal
cells, and may cause strong adverse reactions while
providing only low anti-cancer efficiency. Traditional
liposomes and nanomaterials have been shown to have
good biocompatibility, sustained release, and targeting after being modified and improved, and are the
most attractive drug carriers. In evaluating the physical properties and stability of liposomes, AFM is one of
the most effective detection technologies [114]. Lapatinib is a dual inhibitor that is used to treat advanced
breast cancer and some other cancers [115–117]. Lapatinib is poorly soluble in water, but after being encapsulated in lipoproteins to form nanoparticles (LTNPs),
its water solubility increases from 7 μg/mL to 10 mg/
mL or more. AFM measurements showed that LTNPs
are spherical particles, and that the height of the particles is not positively correlated with the diameter, as
the diameter is about 60 nm and the height is less than
3 nm [118].
Carbon nanomaterials are widely used in biomedical devices and biosensors, including carbon nanoparticles (CNP), carbon nanotubes (CNT), and graphene,
etc. [119–121]. One study found that carbon nanoparticles (CB) which were covered using BSA and surface-coupled to methotrexate (methotrexate) to form
complexes (CBM) were better than methotrexate alone
for inhibiting tumor cells [122]. The sizes of CNP, CB,
and CBM were found to range between 16–27, 35–44,
and 51–66 nm, respectively, using AFM. Surface morphological changes were found on functionalized CB
and CBM, which was mainly reflected in the significant change in roughness [122]. Similar conformational
changes were also found when BSA was bound to CNP
[123, 124]. This indicated that CNP could be used as
a nano-carrier to connect anticancer drugs with their
corresponding target cells. The surface structure of
these nanoparticles or nanocomposites can be quickly
determined by AFM [125], allowing for the possible
function and work scope of the nano-composites to be
predicted.
AFM can assist in the evaluation, screening, and
development of anti-cancer drugs. Therapeutic methods that can cause changes in the morphology and
mechanical properties of cancer cells can be detected
by AFM, which provides an aid for the diagnosis and
treatment of cancer.
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AFM in combination with other technologies
The distal metastasis of cancer is the cause of death
in most cancer patients. Understand the differences
between primary cancer cells and metastatic cancer
cells is therefore critical for the diagnosis and treatment
of cancer. At present, it is known that the original cancer cells and metastatic cells have different genetic maps
[126, 127], which can be used in clinical diagnosis. It has
been shown that Raman spectroscopy can successfully
distinguish between cancer and healthy cells, primitive
and metastatic cancer cells, and cancerous and healthy
tissues [128–131]. The prominent advantage of Raman
spectroscopy is that it is possible to know the chemical
composition of the substance [132], which is impossible
for AFM. However, if AFM and Raman spectroscopy are
used together [133], it is possible to not only know the
substance content of the cell surface, but to simultaneously determine the substance’s chemical composition,
thereby enlarging the scope for the use of AFM.
AFM may be combined with a confocal laser scanning
microscope (CLSM) to study the mechanical properties of individual cancer cells [134]. The combination of
AFM and CLSM directly correlates indentation points
with film imaging of subcellular structures [135]. In
the early stage of cancer development, the mechanical
properties and morphology of cells change. Researchers
can detect changes in the elasticity of cancer cells using
AFM and elucidate its relationship to malignancy in the
early transformation process. Alpha-enolase (ENO1) is
a multifunctional protein [136, 137] that is not only one
of the enzymes involved in glycolysis, but also a fibrinogen receptor that promotes cancer metastasis [138–141].
Combined use of AFM and CLSM revealed that ENO1
gene silencing made pancreatic cancer cells coarser, damaging the adhesion between cancer cells, and between
cancer cells and stroma, resulting in the invasion and
metastasis of pancreatic cancer cells [142].
Cervical cancer is the second most common cancer in
women [143]. Accurate and early diagnosis can reduce
costs, greatly benefiting patients. AFM’s high resolution imaging of suspected malignant cells can provide
more information than light microscopy, targeting cells
for accurate diagnosis [144, 145]. It also provides advantages over scanning electron microscopy (SEM) imaging,
allowing for high-resolution 3D imaging, with faster sample preparation, and determining the unique mechanical
properties of cells. However, there are limitations to the
imaging of cervical cancer cells using either AFM or SEM
alone. Multiple forms of detection are more accurate
than those provided by a single format test. The imaging
diagnosis of cervical carcinoma cells with AFM and SEM
has the advantages of fast detection, easy operation, low
cost, and so on [146]. SEM and AFM are currently the
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most common means of surface analysis. However, with
AFM, work area selection is very blind, and the work area
itself is very limited. Scanning can only be done on the
micrometer scale, and it is very difficult to scan larger
sample surfaces. Utilizing the large-scale search capabilities of SEM to find and target features or areas of interest that need to be studied by AFM can greatly improve
the efficiency of analyses. This system can also be used to
detect and diagnose other cancers.
The World Health Organization classifies astrocytomas
based on the microscopic appearance of tumors [147].
However, the details of the complex morphology vary
according to the specific tumor and patient, and the final
classification has to be determined by an experienced
pathologist. Therefore, in order to make the classification
more accurate, more objective criteria need to be determined. The combined use of AFM imaging and Data
Mining Techniques to classify brain tumors is a recentlydeveloped method, achieving 94.74% classification accuracy in distinguishing between type II, III, and IV tumors
[148]. Patients with stage II tumors can quickly be diagnosed using this method, reducing their risk of cancer
metastasis.
AFM imaging and mechanical measurement techniques have been widely used in the biomedical field, and
allows for the determination of cell structure and function from level of single molecules to that of individual
cells. These methods can be used to differentiate between
cancer and normal cells at the single-cell level, and enables visual drug research. No technology lacks drawbacks, and AFM technology does have limitations, but
its use in combination with other complimentary technologies is a developing trend and is expanding the use
of AFM.

Conclusion and prospects
After nearly 30 years of development, AFM has played an
increasingly important role in cell imaging and the study
of the mechanical properties of cells. From initial imaging modes (such as contact and tapping imaging modes)
and force curve-based mechanical measurement modes
to today’s high-speed imaging mode (such as fast-scan
mode) [149] and high-resolution mechanical measurements modes (such as peak force mode) [150, 151] make
AFM increasingly important in the study of cell physicochemical properties. The mechanical properties of cells
can be used as a new diagnostic physical biomarker to
supplement traditional tissue detection [152]. However,
there are still many problems to be solved before the
application of AFM technology can be fully realized in
practice (for example, in the diagnosis of cancer).
The usage efficiency and the temporal resolution
should be improved. At present, AFM measurement
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of cells mainly depends on manual operation, including manual control of the probes to target cells, manual
parameter setting to obtain cell force curves, and manual offline processing of experimental data. This leads
to very low experimental efficiency, and it takes several
minutes to take a measurement of a cell [8]. In particular, in order to obtain statistically significant conclusions, many cells need to be measured, which results in
a large workload, and limits the practical application of
AFM at the single cell level. Therefore, improving AFM’s
level of automation will help improve its measurement
efficiency. In addition, the response time of the cell to
the environment is approximately 1 ms, which is significantly shorter than AFM’s mechanical mapping time
(about 10 min) [153]. This has made it difficult to monitor changes in the mechanical properties of cells in real
time. Although HS-AFM has been commercialized [154],
with available systems having imaging times of less than
100 ms [155], and is suitable for imaging rigid and flat
small-size samples, such as substrate-bound molecules
[156] and microbial cell walls [157], increasing the speed
of AFM detection will be of use in real-time studies of
changes in the dynamic mechanical properties of cells
[158, 159]. High-speed AFM can also be used for imaging
of mammalian cells [160]. The imaging time is, on average, approximately 5 s, far larger than the response time
of cells to external stimuli.
The standardization of AFM measurements is another
requirement. Young’s modulus is a value commonly
reported when AFM is used to measure the mechanical
properties of cell, but is dependent on the conditions of
the experiment, including the environment (temperature,
substrate, culture medium) [161], instrument parameters
(loading rate, indentation depth) [162], cell (cell position
constrained, cell state) [163], data analysis (e.g., pattern

selection, contact point determination) [164], and so on.
The results of different studies can only be compared
when the conditions are in full agreement, and it is difficult for researchers to maintain identical experimental
conditions. Therefore, in order to make the measurement results of different research groups comparable, the
measurement process needs to be standardized, as does
sample treatment.
For clinical and practical applications, multiple clinical cases are needed to verify the reliability of mechanical property detection. Sample preparation and AFM
measurements need to be standardized, and the relative
values characteristic of cancer cells and normal cells
need to be determined. Some studies directly measure
the mechanical properties of the original cancer tissue, which allows for detection of the different stages
of tumor metastasis [165, 166]. However, tumor tissue
includes cancerous cells, normal cells, blood vessels,
and extracellular matrix [167], which means that such
measurements describe the mechanical properties of
the local tissue, and not of isolated cancer cells. The
most difficult part of the measurement is to determine
the contribution of each component to the mechanical
properties of cancerous tissue. Studies have shown that
other non-tumor cells in tumor tissues also affect the
development and metastasis of tumors [168]. In addition, tumor tissue is highly heterogeneous, with differences manifesting in different tumor tissues as well as
in different parts of the same tissue [169]. Therefore,
tumor tissues in different locations may have different
mechanical properties, and different parts of the tissue
need to be extracted for comparative detection.
In recent years, many AFM models have been developed [170–172]. Together with advances in complementary techniques (Table 2), this will allow AFM to

Table 2 Comparison of high-resolution imaging techniques in molecular and cell biology [171]
Technique/
feature
Resolution

Atomic force microscopy

Super-resolution microscopy Transmission electron
(STED, PALM, STORM)
microscopy

Scanning election
microscopy
2–10 nm

≤ 1 nm–50 nm

20–50 nm

Sample preparation and
environment

Sample on support; physiological
(buffer solution, temperature,
CO2)

Fluorescence labelling;
Sample on grid; dehydrated
physiological (buffer solution,
(negative stain); vitrified
temperature, CO2)
(cryo-electron microscopy)

0.2–10 nm

Freeze/critical point drying
and metal shadowing

Artefacts

Tip, force, scanning

Bleaching, toxicity

Dehydration, ice crystal formation, beam damage

Dehydration, metal shadowing, beam damage

Advantages

Imaging under native conditions;
no staining, labelling, or fixation
necessary; high signal-to-noise
ratio; assessment of multiple
physical, chemical, and biological parameters

Access to three-dimensional
cellular structures; high
spatiotemporal resolution;
monitoring biomolecular
processes in life cells

Solves atomic structures of
Imaging surfaces of tissues,
proteins; conformational
cells, and interfaces as
snapshot of proteins and
nanometer-scale resolution
complexes; molecular resolution of structures within
the cell

Limitation

Restricted to surfaces

Imaging restricted to fluorescence labels

No life processes

No life processes

STED stimulated emission depletion, PALM photo activated localization microscopy, STORM stochastic optical reconstruction microscopy
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address outstanding questions in biology in the coming
decades. These have made the AFM easier to apply to
biological systems, which has resulted in more information on these systems being generated.
Currently, the sensitivity and temperature stability
(drift) of AFM limits its accuracy in describing biological systems. The recently introduced ultra-stable AFM
can provide the accuracy of sub-pico force while providing high stability (< 0.03 Å) at very low lateral drift
(~ 5 pm min) [173, 174]. We predict that with the continuous development and improvement of AFM technology, it will play an increasingly important role in
cancer research and diagnosis.
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